These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21384742)

  • 41. Relationship between advanced glycation end products and increased lipid peroxidation in semen of diabetic men.
    Karimi J; Goodarzi MT; Tavilani H; Khodadadi I; Amiri I
    Diabetes Res Clin Pract; 2011 Jan; 91(1):61-6. PubMed ID: 20970866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus.
    Koga M; Murai J; Morita S; Saito H; Kasayama S
    J Diabetes Complications; 2013; 27(3):211-3. PubMed ID: 23312788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pentosidine plasma levels and relation with metabolic control in diabetic patients.
    Lapolla A; Reitano R; Baccarin L; Sartore G; Plebani M; Fedele D
    Horm Metab Res; 2005 Apr; 37(4):252-6. PubMed ID: 15952087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
    Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
    Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes.
    Matsumoto H; Murase-Mishiba Y; Yamamoto N; Sugitatsu-Nakatsukasa S; Shibasaki S; Sano H; Terasaki J; Imagawa A; Hanafusa T
    Intern Med; 2012; 51(11):1315-21. PubMed ID: 22687835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlations Between Glycemic Parameters Obtained from Continuous Glucose Monitoring and Hemoglobin A1c and Glycoalbumin Levels in Type 2 Diabetes Mellitus.
    Sonoda S; Okada Y; Torimoto K; Sugai K; Uemura F; Tanaka K; Hajime M; Mori H; Tanaka Y
    J UOEH; 2020; 42(4):299-306. PubMed ID: 33268606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of diabetes duration and glycemic control on free radicals in children with type 1 diabetes mellitus.
    Hsu WT; Tsai LY; Lin SK; Hsiao JK; Chen BH
    Ann Clin Lab Sci; 2006; 36(2):174-8. PubMed ID: 16682514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy.
    Loho T; Venna V; Setiabudy RD; Sukartini N; Immanuel S; Kumalawati J; Victor AA; Waspadji S
    Acta Med Indones; 2018 Apr; 50(2):132-137. PubMed ID: 29950532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
    Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
    Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies.
    Pertyńska-Marczewska M; Głowacka E; Sobczak M; Cypryk K; Wilczyński J
    Am J Reprod Immunol; 2009 Feb; 61(2):175-82. PubMed ID: 19143681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
    Sözmen EY; Sözmen B; Delen Y; Onat T
    Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control.
    Takahashi S; Uchino H; Shimizu T; Kanazawa A; Tamura Y; Sakai K; Watada H; Hirose T; Kawamori R; Tanaka Y
    Endocr J; 2007 Feb; 54(1):139-44. PubMed ID: 17159300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.
    Schalkwijk CG; Ter Wee PM; Stehouwer CD
    Ann N Y Acad Sci; 2005 Jun; 1043():662-70. PubMed ID: 16037290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
    Gan T; Liao B; Xu G
    J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study.
    Lu JM; Ji LN; Li YF; Li QM; Lin SS; Lv XF; Wang L; Xu Y; Guo XH; Guo QY; Ma L; Du J; Chen YL; Zhao CL; Zhang QL; She QM; Jiao XM; Lu MH; Pan RQ; Gao Y
    J Diabetes Complications; 2016; 30(8):1609-1613. PubMed ID: 27496253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
    Aso Y; Inukai T; Tayama K; Takemura Y
    Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.